Atlas Trials

Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.

Clinical trial NCT00759720 · TERMINATED

Trial details

NCT number
NCT00759720
Sponsor
Takeda
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2003-11-01
Primary completion
2004-12-01
Enrollment
447

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.